In the midbrain, there were some trends for decreased PAD2 and PAD4 protein levels in the PD model, which correlates with fewer citrullinated protein hits identified in the PD midbrain, and this also correlated with fewer KEGG pathways unique to the PD midbrain, compared with controls. This evidence concerns the gene PADI2 and Parkinson disease.